切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2015, Vol. 01 ›› Issue (02) : 76 -79. doi: 10.3877/cma.j.issn.2095-9605.2015.02.006

临床研究

代谢手术对肥胖伴或不伴2 型糖尿病的疗效分析
施晨晔1, 常薪霞2, 颜红梅2, 卞华2, 周荻3, 楼文晖1, 秦新裕1, 高鑫2, 吴海福1,()   
  1. 1.200032 上海,复旦大学附属中山医院普外科
    2.200032 上海,复旦大学附属中山医院内分泌科
    3.200032 上海,复旦大学附属中山医院麻醉科
  • 收稿日期:2015-03-22 出版日期:2015-08-30
  • 通信作者: 吴海福

Curative effect analysis of metabolic surgery for obesity with or without type 2 diabetes mellitus

Chenye Shi1, Xinxia Chang2, Hongmei Yan2, Hua Bian2, Di Zhou3, Wenhui Lou1, Xinyu Qin1, Xin Gao2, Haifu Wu1,()   

  1. 1.Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    2.Department of Endocrinology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    3.Department of anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2015-03-22 Published:2015-08-30
  • Corresponding author: Haifu Wu
引用本文:

施晨晔, 常薪霞, 颜红梅, 卞华, 周荻, 楼文晖, 秦新裕, 高鑫, 吴海福. 代谢手术对肥胖伴或不伴2 型糖尿病的疗效分析[J/OL]. 中华肥胖与代谢病电子杂志, 2015, 01(02): 76-79.

Chenye Shi, Xinxia Chang, Hongmei Yan, Hua Bian, Di Zhou, Wenhui Lou, Xinyu Qin, Xin Gao, Haifu Wu. Curative effect analysis of metabolic surgery for obesity with or without type 2 diabetes mellitus[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2015, 01(02): 76-79.

目的

探讨代谢手术治疗肥胖伴或不伴2 型糖尿病的疗效。

方法

回顾性分析2013 年1 月至2014 年12 月在复旦大学附属中山医院接受代谢手术治疗的26 例患者的临床资料。其中男11 例,女15 例;年龄19~64 岁。16 例被诊断为肥胖合并2 型糖尿病;5 例被诊断为糖尿病前期(空腹血糖受损及糖耐量减低);5 例被诊断为单纯性肥胖症。收集并对比26 例患者手术前后的代谢参数指标。

结果

分别有16 例、13 例和10 例患者完成术后3 个月、6 个月和1 年随访。术后患者体重与BMI 呈下降趋势(P <0.05)。术后3 个月空腹血糖(5.5±1.3)mmol/L,餐后2 小时血糖(8.6±3.8)mmol/L,糖化血红蛋白(6.46±0.76)%;术后6 个月空腹血糖(4.8±0.7)mmol/L,餐后2 小时血糖(7.2±3.4)mmol/L,糖化血红蛋白(5.56±0.49)%;术后1 年血糖水平高于术后6 个月。术后3 个月、6 个月和1 年,肝脏脂肪含量平均下降分别为21.6%、25.1%和25.1%。

结论

代谢手术能明显降低患者体重、改善糖代谢情况。对于重度单纯性肥胖伴或不伴2 型糖尿病患者,手术治疗是减轻体重及肝脏脂肪含量、治疗糖尿病行之有效的手段。

Objective

To explore the curative effect of metabolic surgery for obesity with or without type 2 diabetes mellitus.

Methods

Clinical data of 26 patients undergoing metabolic surgery in Zhongshan Hospital of Fudan University from January 2013 to December 2014 was retrospectively analyzed. Among them, 11 were males and 15 were females, with the age ranging from 19 to 64 years old.16 cases were diagnosed as obesity combined with type 2 diabetes; 5 cases were diagnosed as prediabetes(impaired fasting glucose and glucose tolerance); 5 cases were diagnosed as simple obesity. Metabolic parameters of these 26 patients before and after surgery were collected and compared.

Results

Sixteen patients were followed up postoperatively for 3 months, 13 patients for 6 months and 10 patients for 1 year.Weight and BMI decreased over time after surgery (P<0.05). At the 3 months postoperatively, average fasting blood glucose level was (5.5±1.3) mmol/L, 2-hour postprandial blood glucose was (8.6±3.8)mmol/L and HbA1c was (6.46±0.76)%. At the 6 months postoperatively, average fasting blood glucose level was (4.8±0.7) mmol/L, 2-hour postprandial blood glucose was (7.2±3.4) mmol/L and HbA1c was(5.56±0.49)%. Blood glucose level at 1 year after surgery was higher than that at 6 months. Average decline of liver lipid content were 21.6%, 25.1% and 25.1% respectively at 3 months, 6 months and 1 year after surgery.

Conclusions

Metabolic surgery can significantly reduce weight and improve blood glucose metabolism. For severe simple obesity with or without type 2 diabetes mellitus, surgical treatment is an effective method to reduce weight, liver lipid content and treat diabetes.

表1 26 例肥胖患者代谢手术前后代谢参数变化(±s
[1]
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013:a systematic analysis for the Global Burden of Disease Study[J]. Lancet, 2014, 384(9945):766-781.
[2]
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis[J]. Am J Med, 2009, 122(3):248-256.
[3]
Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes:a systematic review[J]. JAMA, 2013, 309(21):2250-2261.
[4]
Dixon JB, O'Brien PE, Playfair J,et al.Adjustable gastric banding and conventional therapy for type 2 diabetes:a randomized controlled trial[J]. JAMA, 2008, 299(3):316-323.
[5]
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med,2012, 366(17):1577-1585.
[6]
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012, 366(17):1567-1576.
[7]
Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes,hypertension, and hyperlipidemia:the Diabetes Surgery Study randomized clinical trial[J]. JAMA, 2013, 309(21):2240-2249.
[8]
Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications[J]. JAMA, 2014,311(22):2297-2304.
[9]
Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE comprehensive diabetes management algorithm 2013[J]. Endocr Pract, 2013,19(2):327-336.
[10]
Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery:an IDF statement for obese Type 2 diabetes[J]. Diabet Med, 2011, 28(6):628-642.
[11]
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy:a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes[J]. Diabetologia, 2009, 52(1):17-30.
[12]
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013版) [J].中国糖尿病杂志, 2014, 22(8):2-42.
[13]
Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes:a community-based cohort study[J]. Am J Gastroenterol, 2010,105(7):1567-1573.
[14]
Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus[J]. Gastroenterol Hepatol, 2004,19(8):854-858.
[15]
Bhala N, Jouness RI, Bugianesi E, et al. Epidemiology and natural history of patients with NAFLD[J]. Curr Pharm Des, 2013,19(29):5169-5176.
[16]
Hossain N, Afendy A, Stepanova M, et al. Independent predictors of fibrosiss in patients with nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2009, 7(11):1224-1229.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[3] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[4] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[5] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[6] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 杜军霞, 赵小淋, 王浩然, 高志远, 王曼茜, 万楠熙, 张冬, 丁潇楠, 任琴琴, 段颖洁, 汤力, 朱晗玉. 2 型糖尿病的血液透析患者肠道微生物组学高通量测序分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 313-320.
[9] 刘辉, 海燕. 集束化护理在预防减重代谢手术患者术中压力性损伤中的应用[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 169-173.
[10] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 227-234.
[11] 李兆, 李兆鹏, 宋逸, 郭栋, 陈栋, 李宇. 腹腔镜袖状胃切除术后残胃容积的测量方案及评价[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 242-247.
[12] 王鹏鹏, 周涵苓, 孟化, 刘宝胤. 减重手术后皮肤松弛的塑形手术现状与展望[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 248-254.
[13] 赖慧香, 林清然, 董志勇, 高丽莲, 杨华, 中国肥胖代谢外科研究协作组. 减重手术后患者饮食管理评估工具的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 220-225.
[14] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识(2024版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
[15] 王思奇, 张念荣, 周彪, 刘宝胤, 孟化. 肥胖与胆囊疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 177-183.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?